Zim Labs board approves about INR 35 crore preferential issue to Florintree

Fund Raising View source PDF Explain this filing

ZIMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.5%Reaction day

₹76.77

prior close

₹71.18

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-7.7% vs market

On the reaction day the stock moved 7.7 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

-0.0

15m

+0.3

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-8.5-0.8-7.7

Next day

-8.2+0.7-8.9

-7.8-1.4-6.4

-8.9-1.3-7.7

-4.6+0.7-5.3

-5.5+0.3-5.8

-4.5+0.9-5.4

15d

-4.3+6.8-11.0

-8.7+4.3-12.9

-20.9-8.7-12.2

+10.7+8.6+2.1

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zim Laboratories board on Jan 21 approved issuing up to 47.64 lakh equity shares to Florintree Trinex LLP at INR 73.46 per share, raising about INR 35 crore. The investor is not part of the promoter group and will hold up to 8.91 percent post-issue. Shareholders approval will be sought at an EGM on Feb 16, 2026.

Likely market impact

Equity dilution of about 8.91 percent for existing shareholders. A known investor coming in may be viewed positively by the market.